CONGENITAL ADRENAL HYPERPLASIA: SYMPTOMS AND ITS CHALLENGES

• Autor(a) principal: Lima, João Luiz Silva de
• Data de Publicação: 2023
• Outros Autores: Morais , Sabrina Karen Meneses, Grassioli , Lucas Guimarães, Neto, Humberto Arruda Carneiro, Carneiro, Vyctor Mont`Alverne Napoleão
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Brazilian Journal of Implantology and Health Sciences
• Texto Completo: https://bjihs.emnuvens.com.br/bjihs/article/view/985
• topic: Caproato de 17 alfa-Hidroxiprogesterona, Triagem Neonatal, Hiperplasia Suprarrenal Congênita.; : 17 alpha-Hydroxyprogesterone caproate, Neonatal Screening, Congenital Adrenal Hyperplasia.

The objective of the above study is to analyze, according to scientific literature, the main symptoms and preventive measures for diagnosing congenital adrenal hyperplasia. This is an integrative review of the literature that has the character of a descriptive study and a qualitative approach, in which the survey was carried out in the Virtual Health Library system of the Ministry of Health using the following descriptors: 17 Alpha-hydroxyprogesterone caproate, neonatal, screening and congenital adrenal hyperplasia. Initially, 234 results were found without filters. and subsequent applications were reduced to 45 studies, and from these the resulting titles were read in the database, leaving only 09 articles for the sample in the final qualitative synthesis. From analysis of the literature it was established that hyperadrenal hyperplasia (CHS) is a genetic disease that affects the adrenal glands. This results in insufficient production of steroid hormones. The adrenal glands are essential for the functioning of the body as they produce hormones responsible for regulating several important functions. Therefore, if SCH is not treated appropriately, serious complications such as salt crisis and hormonal imbalance can occur. These complications may require hospitalization and negatively impact the child's quality of life. Through the study it was found that the implementation of neonatal screening strategies, public awareness and education, as well as adequate access to laboratory tests, are essential for the early identification and treatment of CAH. Hopefully with continued research and collaborative efforts. This will create better treatment options. and a better prognosis for children suffering from SCH.